Unicycive Therapeutics, Inc. (UNCY)
3.585
-0.12
(-3.11%)
USD |
NASDAQ |
Oct 15, 16:00
3.65
+0.06
(+1.81%)
After-Hours: 20:00
Unicycive Therapeutics Price to Book Value : 1.875 for Oct. 15, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 1.935 |
| October 13, 2026 | 1.950 |
| October 12, 2026 | 2.118 |
| October 09, 2026 | 2.149 |
| October 08, 2026 | 2.128 |
| October 07, 2026 | 2.186 |
| October 06, 2026 | 2.212 |
| October 05, 2026 | 2.191 |
| October 02, 2026 | 2.207 |
| October 01, 2026 | 2.379 |
| September 30, 2026 | 2.455 |
| September 29, 2026 | 2.379 |
| September 28, 2026 | 2.426 |
| September 25, 2026 | 2.455 |
| September 24, 2026 | 2.515 |
| September 23, 2026 | 2.515 |
| September 22, 2026 | 2.594 |
| September 21, 2026 | 2.494 |
| September 18, 2026 | 2.51 |
| September 17, 2026 | 2.494 |
| September 16, 2026 | 2.500 |
| September 15, 2026 | 2.463 |
| September 14, 2026 | 2.693 |
| September 11, 2026 | 2.766 |
| September 10, 2026 | 2.777 |
| Date | Value |
|---|---|
| September 09, 2026 | 2.677 |
| September 08, 2026 | 2.630 |
| September 04, 2026 | 2.698 |
| September 03, 2026 | 2.771 |
| September 02, 2026 | 2.714 |
| September 01, 2026 | 2.641 |
| August 31, 2026 | 2.719 |
| August 28, 2026 | 2.753 |
| August 27, 2026 | 2.876 |
| August 26, 2026 | 2.839 |
| August 25, 2026 | 2.860 |
| August 24, 2026 | 2.792 |
| August 21, 2026 | 2.944 |
| August 20, 2026 | 2.850 |
| August 19, 2026 | 2.918 |
| August 18, 2026 | 2.944 |
| August 17, 2026 | 2.913 |
| August 14, 2026 | 2.881 |
| August 13, 2026 | 2.824 |
| August 12, 2026 | 2.818 |
| August 11, 2026 | 2.614 |
| August 10, 2026 | 2.625 |
| August 07, 2026 | 2.651 |
| August 06, 2026 | 2.641 |
| August 05, 2026 | 2.735 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.594 |
| Alnylam Pharmaceuticals, Inc. | 23.11 |
| Anika Therapeutics, Inc. | 2.019 |
| Savara, Inc. | 6.798 |
| Vericel Corp. | 5.671 |
Price to Book Value Related Metrics
| Price | 3.585 |
| Earnings Yield | -44.53% |
| Market Cap | 99.86M |